Browse medicines, page 32 of 40

Use listed on the medicine record

Community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms

Use listed on the medicine record

Pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Use listed on the medicine record

HIV-1 infection

Use listed on the medicine record

Metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy

Use listed on the medicine record

as Antacid • relieves • heartburn • sour stomach • acid indigestion • and upset stomach associated with these symptoms Uses as Saline Laxative • for relief of occasional constipation (irregularity) • this product generally produces bowel movement in 1/2 to 6 hours

Use listed on the medicine record

Infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair

Use listed on the medicine record

Cholestatic pruritus

Use listed on the medicine record

LIVTENCITY ® is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see Use in Specific Populations (8.4) and Clinical Studies (14) ] .

Use listed on the medicine record

Moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension

Use listed on the medicine record

Idiopathic heavy menstrual blood loss

Use listed on the medicine record

INDICATIONS For the temporary relief of diarrhea, gas, cramping, fatigue, minor joint pain or swelling, or occasional headache due to sensitivity to phenolic compounds found in foods or other products.*

Use listed on the medicine record

Pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Use listed on the medicine record

POLOCAINE (Mepivacaine HCl Injection, USP), is indicated for production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. The routes of administration and indicated concentrations for mepivacaine are: local infiltration 0.5% (via dilution) or 1 % peripheral nerve blocks 1% and 2% epidural block 1%, 1.5%, 2% caudal block 1%, 1.5%, 2% See DOSAGE AND ADMINISTRATION for additional information.

Use listed on the medicine record

Anxiety disorders or for the short-term relief of the symptoms of anxiety

Use listed on the medicine record

BIOCORNEUM ® can reduce the appearance of scars and is ideal for use on any intact skin surface, including skin that flexes (such as joints) and areas exposed to sun (such as the face and hands).

Use listed on the medicine record

Methohexital Sodium for Injection can be used in adults as follows: 1.For intravenous induction of anesthesia prior to the use of other general anesthetic agents. 2.For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; Methohexital Sodium for Injection may be given by infusion or intermittent injection.

Use listed on the medicine record

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

Use listed on the medicine record

Joint pain, muscle pain, and inflammation associated

Use listed on the medicine record

Metyrosine capsules are indicated in the treatment of patients with pheochromocytoma for: 1. Preoperative preparation of patients for surgery. 2. Management of patients when surgery is contraindicated. 3. Chronic treatment of patients with malignant pheochromocytoma. Metyrosine capsules are not recommended for the control of essential hypertension.

Use listed on the medicine record

Documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening

Use listed on the medicine record

The treatment of adult patients

Use listed on the medicine record

GALAFOLD is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene ( GLA ) variant based on in vitro assay data [see Dosage and Administration (2.1) and Clinical Pharmacology (12.1) ] . This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate [see Clinical Studies (14) ] . Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.

Use listed on the medicine record

Fibromyalgia

Use listed on the medicine record

IMPAVIDO (miltefosine) capsules are indicated in adults and adolescents ≥12 years of age weighing ≥ 30 kg for the treatment of: Visceral leishmaniasis caused by Leishmania donovani [see Clinical Trials ( 14.1 )] . Cutaneous leishmaniasis caused by Leishmania braziliensis , Leishmania guyanensis , and Leishmania panamensis [see Clinical Trials ( 14.2 )] . Mucosal leishmaniasis caused by Leishmania braziliensis [see Clinical Trials ( 14.3 )] .

Use listed on the medicine record

The nausea and vomiting associated with cancer chemotherapy

Use listed on the medicine record

Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Nabumetone tablets, USP are indicated: For relief of the signs and symptoms of rheumatoid arthritis. For relief of the signs and symptoms of osteoarthritis.

Use listed on the medicine record

Nafcillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. Culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug (see CLINICAL PHARMACOLOGY - Susceptibility Test Methods ). Nafcillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results. Nafcillin should not be used in infections caused by organisms susceptible to penicillin G.

Use listed on the medicine record

The emergency treatment of known or suspected overdose induced by natural or synthetic opioids

Use listed on the medicine record

First remove the protective cap, before first use, press several times until liquid squirts out, then insert the nozzle into the nostril, press firmly, pull the nozzle out of the nostril before releasing, then release, close the cap for protection.

Use listed on the medicine record

Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi [see Clinical Studies ( 14 )]

Use listed on the medicine record

Metastatic prostate cancer

Use listed on the medicine record

Mild-to-moderate coronavirus disease 2019

Use listed on the medicine record

Diarrhea caused by Giardia lamblia or Cryptosporidium parvum

Use listed on the medicine record

Active duodenal ulcer

Use listed on the medicine record

Adults and children 12 years of age and over: apply to affected area not more than 3 to 4 times daily. Children under 12 years of age: do not use, consult a doctor For easy application: partially peel back protective film and apply exposed patch to the site of pain. Carefully remove remaining film while pressing patch to skin for secure adhesion.